Global 3D Cell Culture Market by Technology (Extracellular Matrices or Scaffolds, Bioreactors, Gels, Scaffold-free Platforms, and Microchips), by Application (Research, Drug Discovery, Tissue Engineering, Clinical Applications, and Stem Cell Biology), by End User (Research Labs & Institutes, Biopharmaceutical Industry, Hospitals And Diagnostic Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - is estimated to be valued at US$ 2,604.3 Mn in 2020 and is expected to exhibit a CAGR of 23.4% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.
The rising prevalence of cancer and infectious diseases are expected to propel growth of the global 3D cell culture market over the forecast period. The rising demand for 3D cell culture for treatment of various diseases, owing to increasing prevalence of cancer and infectious diseases is expected to boost the 3D cell culture market growth over the forecast period.
For instance, according to the World Health Organization (WHO): September 2018 data finding, cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths globally in 2018. Furthermore, according to the same source, globally, about one in six deaths occur due to cancer.
In addition, according to the American Cancer Society, in 2019, an estimated 1,762,450 new cancer cases were diagnosed and 606,880 cancer deaths were reported in the U.S.
Global 3D Cell Culture Market– Impact of Coronavirus (COVID-19) Pandemic
3D cell culture techniques are emerging as versatile and biologically relevant research models to help support the current fight against COVID-19. Stem cells are emerging as a favored model to predict what type of cell can be permissive to certain types of viruses, giving insight to scientists and clinicians alike and offering advantages over the limited resources of biobanks for human tissue, in vitro Petri dish cultures or animal models. Several companies are supporting the research and development activities using 3D cell cultures for development of new screening and therapy platforms. For instance, in January 2021, Corning Incorporated highlighted its latest technologies that support the advancement of 3D cell culture, automation, and drug discovery as new solutions to support evolving industry needs such as COVID-19 response, disease models, and drug discovery at this year's 2021 virtual Society for Laboratory Automation and Screening (SLAS) conference. Moreover, in November 2020, Biogelx is aiming to provide UK-Spanish research groups working on COVID-19 vaccines with advanced 3D cell culture to mitigate risk arising during drug development and testing processes. Biogelx is committed to supporting the scientific community working on COVID-19 vaccines research. In October 2020, a study published in Cell Press Journal, reported that a team of scientists from the U.K. and South Korea turned to organoids—'miniorgans' grown in three dimensions to mimic the behavior of tissue and organs. The scientists were able to grow self-organizing alveolar-like 3D structures that mimic the behavior of key lung tissue for understanding how the COVID-19 affects the lungs. The mini-lungs grown from tissue donated to Cambridge hospitals have provided a team of scientists with important insights into how COVID-19 damages the lungs. In new work, the researchers explained the mechanisms underlying SARS-CoV-2 infection and the early innate immune response in the lungs.
Browse 34 Market Data Tables and 36 Figures spread through 172 Pages and in-depth TOC on “Global 3D Cell Culture Market”- Forecast to 2027, by Technology (Extracellular Matrices or Scaffolds, Bioreactors, Gels, Scaffold-free Platforms, and Microchips), by Application (Research, Drug Discovery, Tissue Engineering, Clinical Applications, and Stem Cell Biology), by End User (Research Labs & Institutes, Biopharmaceutical Industry, Hospitals And Diagnostic Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
Moreover, key players in the market are focusing on adopting inorganic growth strategies such as partnerships, in order to enhance their market share and is also expected to aid in growth of the global 3D cell culture market over the forecast period. For instance, in June 2020, Lonza Group entered into a partnership with the Sweden-based company, CELLINKto offer a comprehensive 3-dimensional (3D) bioprinting solution designed to optimize and increase access to complete 3D cell culture workflows.
Key Takeaways of the Global 3D Cell Culture Market: